Skip to main content

Mass Tort News

First Bard Hernia Mesh Bellwether Trial Slated For Sept 29

Categories: General

On September 29, the first bellwether case in Bard hernia mesh lawsuits will go before the federal jury for which the U.S. District Judge has outlined the pretrial and…

AndroGel Maker Win the Third Bellwether Case

Categories: General

AndroGel maker AbbVie, won the verdict in the third bellwether case as the jury found that the testosterone replacement therapy maker was not…

Nexium: MDL No. 2757

Categories: General

Nexium: MDL No. 2757; in re: Proton-pump inhibitor Products liability litigation, created in August 2017, presided by Judge Claire C. Cecchi, in the U.S. District of New Jersey. Other…

Filing of Hip Replacement Lawsuit on the Rise

Categories: General

A metal-on-metal hip litigation, centralized since May 2017 and involving at least 200 Smith & Nephew Birmingham lawsuits, is witnessing a steady inflow of product liability cases. Recently, a lawsuit was filed by a Minnesota man in the U.S.…

Talcum Powder Lawsuit Filed Over Omitted Safety Information

Categories: General

A group of plaintiffs has filed a class action lawsuit against Johnson & Johnson for not updating the Talcum Powder label to warn the consumers, especially women…

PPI Plaintiffs Request Judge to Club 300 Individuals Cases

Categories: General

Gauging filing Short Form Complaint would not suffice to handle the wave of expected PPI lawsuits, Co-Lead Counsel for the plaintiffs filed a proposed case management order (PDF), requesting temporary clubbing of at least 300 plaintiffs…

Defendants Deny Asbestos Presence in Talcum Powder

Categories: General

During the closing arguments of a Mesothelioma lawsuit, the counsel representing defendants Johnson & Johnson and its talc supplier, Imerys Talc America Inc., and Cyprus Amax Minerals Co., an Imerys predecessor, stated that the…

Ovarian Cancer Urges a Woman to File a Lawsuit against J&J

Categories: General

A lawsuit was filed against Johnson & Johnson, Imerys Talc America, and Personal Care Products Council in the U.S. District Court for the District of Massachusetts by a woman from Massachusetts, who alleges that the long-term use of…

Jury Supports AbbVie Again in The Fifth Bellwether Trial

Categories: General

The fifth bellwether trial in the multidistrict litigation (MDL) over AbbVie Inc.'s testosterone replacement therapy (TRT) drug AndroGel…

Antidote AndexXa to have a Restricted Release: Portola CEO

Categories: General

AndexXa, the only antidote for Factor Xa blood thinner, approved by the U.S. Food and Drug Administration(FDA) on May 4 to reverse uncontrollable bleeding problems, will be initially available in only those 40 to 50 hospitals where the…